The Interplay between Muscular Grip Strength and Bone Mineral Density with Consideration of Metabolic and Endocrine Parameters in Individuals with Turner Syndrome
- PMID: 38137346
- PMCID: PMC10740630
- DOI: 10.3390/biomedicines11123125
The Interplay between Muscular Grip Strength and Bone Mineral Density with Consideration of Metabolic and Endocrine Parameters in Individuals with Turner Syndrome
Abstract
Introduction: Patients with Turner syndrome (TS) often face skeletal and muscular challenges, including reduced bone mineral density (BMD) and muscle weakness. This comprehensive study sheds light on the complex interplay between muscle strength, BMD, and metabolic and endocrine parameters in TS and healthy subjects.
Methods: A cross-sectional study involving 42 TS patients and 70 healthy women was conducted. All patients had their BMD determined in the L1-L4 lumbar spine section and in the whole skeleton as well as the parameters of body fat mass (BF), and visceral fat mass (VF) were also determined. The maximum gripping force was measured with a hydraulic manual dynamometer. In addition, a number of blood hormonal and metabolic parameters were determined.
Results: In the TS group, hand grip strength correlated positively with triglyceride levels but not with BMD. Healthy individuals had a positive link between hand grip strength and BMD, while patients with TS did not show a significant association between the two. A trend suggested that longer recombinant human growth hormone (rhGH) therapy might improve BMD in the L1-L4 region. Multiple linear regression analysis revealed that muscle strength assessment may be a potential exponent of reduced BMD, and also used clinically in young adult women but not in individuals with TS.
Conclusions: The relationship between BMD variables and hand grip might differ between the two groups, potentially indicating distinct musculoskeletal characteristics in TS patients. Longer rhGH therapy in TS patients may have a positive effect on BMD in the L1-L4 region. Understanding the intricate relationships between these factors is important for optimizing clinical management strategies and improving the quality of life for TS patients.
Keywords: T syndrome; bone mineralization; hormone replacement therapy; hypogonadism; muscle mass; muscle strength.
Conflict of interest statement
Author Karolina Gruca-Stryjak was employed by the company Centers for Medical Genetics GENESIS, ul. Jana Henryka Dąbrowskiego 77A, 60-406 Poznań, Poland. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration.Biomedicines. 2023 May 29;11(6):1574. doi: 10.3390/biomedicines11061574. Biomedicines. 2023. PMID: 37371669 Free PMC article.
-
Effect of Growth Hormone and Estrogen Replacement Therapy on Bone Mineral Density in Women with Turner Syndrome: A Meta-Analysis and Systematic Review.Pharmaceuticals (Basel). 2023 Sep 19;16(9):1320. doi: 10.3390/ph16091320. Pharmaceuticals (Basel). 2023. PMID: 37765128 Free PMC article. Review.
-
Effect of Hormone Replacement Therapy on Bone Mineral Density and Body Composition in Chinese Adolescent and Young Adult Turner Syndrome Patients.Front Endocrinol (Lausanne). 2019 Jun 12;10:377. doi: 10.3389/fendo.2019.00377. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31244781 Free PMC article.
-
The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.Clin Endocrinol (Oxf). 2008 May;68(5):769-72. doi: 10.1111/j.1365-2265.2007.03107.x. Epub 2007 Nov 2. Clin Endocrinol (Oxf). 2008. PMID: 17980015 Clinical Trial.
-
Fracture risk, underlying pathophysiology, and bone quality assessment in patients with Turner syndrome.Front Endocrinol (Lausanne). 2022 Oct 17;13:967857. doi: 10.3389/fendo.2022.967857. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36325455 Free PMC article. Review.
Cited by
-
Impaired Muscle Parameters in Individuals With Premature Ovarian Insufficiency: A Pilot Study.J Endocr Soc. 2024 Nov 2;8(12):bvae192. doi: 10.1210/jendso/bvae192. eCollection 2024 Oct 29. J Endocr Soc. 2024. PMID: 39574788 Free PMC article.
-
Might Thyroid Function in Patients with Turner Syndrome Have a Significant Impact on Their Muscle Strength?Int J Mol Sci. 2025 Apr 13;26(8):3679. doi: 10.3390/ijms26083679. Int J Mol Sci. 2025. PMID: 40332280 Free PMC article.
References
-
- Schoenau E. From mechanostat theory to development of the “Functional Muscle-Bone-Unit”. J. Musculoskelet. Neuronal Interact. 2005;5:232–238. - PubMed
-
- Fuchs R.K., Shea M. Bone health and resistance exercise. ACSM’s Health Fit. J. 1997;1:30–37.
LinkOut - more resources
Full Text Sources
Miscellaneous